MRK vs TDG · P/E 33, rev $16.61B vs P/E 41, rev $8.83B
Merck & Company Inc (MRK) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the MRK and TDG stock pages for the full models.
Not investment advice.